Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients

NCT01556126 is registered in ClinicalTrials.gov with CID - Carbostent & Implantable Devices as lead sponsor.

NCT NCT01556126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01556126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients
Lead sponsor
CID - Carbostent & Implantable Devices
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2018
Enrollment
1,191 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, stable angina, unstable angina